MK-677 vs LGD-4033: Exploring Their Unique Mechanisms

MK-677 (ibutamoren) and LGD-4033 (ligandrol) are frequently discussed together in research-compound literature, but they are not the same class of compound. This overview describes their research context and does not provide guidance for personal use.

Research classification

MK-677 is generally described in research literature as a ghrelin-receptor agonist or growth-hormone secretagogue. LGD-4033 is generally described as a selective androgen receptor modulator (SARM). Their biological targets are therefore different from the outset.

What researchers distinguish

Aspect	MK-677	LGD-4033
Research classification	Ghrelin-receptor signalling compound	Selective androgen receptor modulator
Primary research focus	Ghrelin and hormone-signalling pathways	Selective androgen receptor interaction
Comparison context	Distinct pathway from SARMs	Frequently discussed in SARM research

Why the distinction matters

A comparison is useful because the terms can appear beside one another in performance-oriented discussions despite referring to different research pathways. That does not make them interchangeable, nor does it establish a personal-use application. Researchers should assess the published literature, classification and legal position relevant to the specific work being undertaken.

Further reading

See the current product information for MK-677 and LGD-4033, the SARMs collection, and the Global SARMs Legality Guide.

Supplied for research purposes only. Not for human or veterinary use.